Related Experiment Video
Updated: May 4, 2026
11:40
Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature
Published on: April 1, 2014
15.1K
Thrombo-embolic complications in bacteraemic infections
V Valtonen1, A Kuikka, J Syrjänen
1Second Department of Medicine, Helsinki University Central Hospital, Finland.
European Heart Journal
|December 1, 1993
Summary
Bacteraemic patients face high risks of stroke and myocardial infarction. Prompt antimicrobial therapy is crucial for reducing these thrombo-embolic complications and improving outcomes.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Hematology
Background:
- Thrombo-embolic events like stroke and myocardial infarction are frequent in patients with bacteremia, with or without endocarditis.
- Infective endocarditis significantly increases stroke risk (approx. 20%), while myocardial infarction is less common but autopsy data reveals high rates of small infarcts (80-90%).
- Bacteremia without endocarditis also carries substantial risks for stroke (approx. 10% within a month) and myocardial infarction (approx. 4%).
Purpose of the Study:
- To investigate the incidence and implications of thrombo-embolic complications in patients with bacteremia.
- To compare the risks of stroke and myocardial infarction in patients with and without infective endocarditis.
- To highlight the role of coagulation system activation and the potential benefits of antimicrobial therapy.
Main Methods:
- Observational analysis of patient data regarding bacteremia and endocarditis.
- Comparison of thrombo-embolic complication rates between different patient groups.
- Review of etiological mechanisms, focusing on coagulation activation.
Main Results:
- Patients with bacteremia have a significantly elevated risk of cerebral or myocardial infarction compared to the general population.
- Approximately 10% of all strokes are linked to bacteremic infections.
- Activation of the coagulation system is identified as a primary mechanism for thrombo-embolic complications in sepsis.
Conclusions:
- Antimicrobial therapy is the cornerstone for reducing mortality and likely mitigating thrombo-embolic complications in bacteremic patients.
- Early and effective treatment of bacteremia is essential for preventing severe cardiovascular events.
- Further research into coagulation pathways in sepsis may yield novel therapeutic targets.
More Related Videos
Related Concept Videos
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
01:30Venous Thrombosis I: Introduction
822
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:29Pulmonary Embolism I: Introduction
1.5K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
01:22Bacterial Meningitis I: Introduction
15
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
01:19Pulmonary Embolism I: Introduction
39
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
39